MELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study

scientific article published on 09 May 2017

MELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.20517/2394-5079.2017.06
P932PMC publication ID5654577
P698PubMed publication ID29075672

P2093author name stringJoy Sarkar
Linda L Wong
Thomas DeLeon
P2860cites workCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Q27861047
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?Q30300505
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center studyQ33403106
Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resectionQ34618740
Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studiesQ34656782
Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomesQ36066060
Transplantation for liver tumorsQ36344612
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listingQ36716640
Epidemiology of hepatocellular carcinoma: consider the populationQ36930514
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting listQ40629471
The role of liver transplantation or resection for patients with early hepatocellular carcinomaQ41194963
Primary surgical resection versus liver transplantation for transplant-eligible hepatocellular carcinoma patientsQ43679100
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.Q44527614
Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?Q47275437
Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behaviorQ47430256
Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score ModelQ48095524
Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?Q81795140
Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implicationsQ82350262
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteriaQ83508509
Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2 cm): a single-center studyQ86573145
P921main subjecthepatocellular carcinomaQ1148337
P304page(s)79-85
P577publication date2017-05-09
P1476titleMELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study
P478volume3

Reverse relations

cites work (P2860)
Q90285730Overexpression of miRNA-21 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma Cells via Suppressing SMAD7
Q58693832Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis

Search more.